Autolus Therapeutics PLC (NASDAQ:AUTL)

1.88
Delayed Data
As of Jan 27
 0.00 / 0.00%
Today’s Change
1.60
Today|||52-Week Range
5.04
-1.05%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Autolus Therapeutics PLC have a median target of 7.00, with a high estimate of 18.00 and a low estimate of 2.20. The median estimate represents a +272.34% increase from the last price of 1.88.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Autolus Therapeutics PLC. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.27
Sales
$11.2M
Reporting Date
Mar 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 42.86%
 
 
 
 
 
 
Growthannually 19.82%
 
 
 
 
 
 

Sales

Growthquarterly 371.93%
 
 
 
 
 
 
Growthannually 1,545.43%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.